IP Group Australia
Overview
IP Group Australia is a venture capital firm that partners with leading research universities in Australia and New Zealand to invest in and build companies based on their intellectual property, focusing on the life sciences, physical sciences, and cleantech sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Hysata | May 2024 | Series B | Co-investor |
| MGA Thermal | Mar 2026 | Grant | Lead |
| RAGE Biotech | Nov 2025 | Series A | Lead |
| Brainomix | Feb 2026 | Series C Extension | Co-investor |
| ElectraLith | Jan 2025 | Series A | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is IP Group Australia based?
IP Group Australia is headquartered in Melbourne, Australia.
When was IP Group Australia founded?
IP Group Australia was founded in 2017.
How many portfolio companies does IP Group Australia have?
IP Group Australia has 7 portfolio companies in Caplight's dataset.
What are some companies in IP Group Australia's portfolio?
Portfolio companies visible on Caplight include Hysata, MGA Thermal, RAGE Biotech, Brainomix, ElectraLith.
What was IP Group Australia's most recent investment shown here?
IP Group Australia's most recent investment in this portfolio sample was in MGA Thermal in 2026.
What sectors does IP Group Australia focus on?
IP Group Australia focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Energy & Sustainability, Mobility, Transportation & Logistics, Energy & Sustainability, Energy & Sustainability, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Enterprise Software, Enterprise Software, Frontier & Industrial Tech.
What company stages does IP Group Australia focus on?
IP Group Australia typically invests at the Early stage.
What is IP Group Australia's AUM?
IP Group Australia's assets under management are estimated between $387.1M and $2.1B.